Knock-down of methyl CpG-binding protein 2 (MeCP2) causes alterations in cell proliferation and nuclear lamins expression in mammalian cells

被引:35
|
作者
Babbio, Federica [1 ]
Castiglioni, Ilaria [1 ]
Cassina, Chiara [1 ]
Gariboldi, Marzia Bruna [1 ]
Pistore, Christian [1 ]
Magnani, Elena [1 ]
Badaracco, Gianfranco [2 ]
Monti, Elena [1 ]
Bonapace, Ian Marc [1 ]
机构
[1] Insubria Univ, Dept Theoret & Appl Sci, I-21052 Busto Arsizio, Italy
[2] Insubria Univ, Dept Biotechnol & Life Sci, I-21100 Varese, Italy
来源
BMC CELL BIOLOGY | 2012年 / 13卷
关键词
Methyl CpG-binding protein 2 (MeCP2); Cell proliferation; Nuclear lamins; GILFORD-PROGERIA-SYNDROME; PROSTATE-CANCER CELLS; DNA METHYLATION; RETT-SYNDROME; B RECEPTOR; DYNAMIC PROPERTIES; ENVELOPE; SENESCENCE; APOPTOSIS; MITOSIS;
D O I
10.1186/1471-2121-13-19
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: MeCP2 (CpG-binding protein 2) is a nuclear multifunctional protein involved in several cellular processes, like large-scale chromatin reorganization and architecture, and transcriptional regulation. In recent years, a non-neuronal role for MeCP2 has emerged in cell growth and proliferation. Mutations in the MeCP2 gene have been reported to determine growth disadvantages in cultured lymphocyte cells, and its functional ablation suppresses cell growth in glial cells and proliferation in mesenchymal stem cells and prostate cancer cells. MeCP2 interacts with lamin B receptor (LBR) and with Heterochromatin Protein 1 (HP1) at the nuclear envelope (NE), suggesting that it could be part of complexes involved in attracting heterochromatin at the nuclear periphery and in mediating gene silencing. The nuclear lamins, major components of the lamina, have a role in maintaining NE integrity, in orchestrating mitosis, in DNA replication and transcription, in regulation of mitosis and apoptosis and in providing anchoring sites for chromatin domains. In this work, we inferred that MeCP2 might have a role in nuclear envelope stability, thereby affecting the proliferation pattern of highly proliferating systems. Results: By performing knock-down (KD) of MeCP2 in normal murine (NIH-3 T3) and in human prostate transformed cells (PC-3 and LNCaP), we observed a strong proliferation decrease and a defect in the cell cycle progression, with accumulation of cells in S/G(2)M, without triggering a strong apoptotic and senescent phenotype. In these cells, KD of MeCP2 evidenced a considerable decrease of the levels of lamin A, lamin C, lamin B1 and LBR proteins. Moreover, by confocal analysis we confirmed the reduction of lamin A levels, but we also observed an alteration in the shape of the nuclear lamina and an irregular nuclear rim. Conclusions: Our results that indicate reduced levels of NE components, are consistent with a hypothesis that the deficiency of MeCP2 might cause the lack of a key "bridge" function that links the peripheral heterochromatin to the NE, thereby causing an incorrect assembly of the NE itself, together with a decreased cell proliferation and viability.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] A Novel Methyl-CpG Binding Protein 2 (MECP2) Variant in an Indian Girl with Rett Syndrome
    Chheda, Pratiksha
    Sekhon, Rubab K.
    Krishnarjun, Muralinath
    Parikh, Khushali D.
    Chandanwale, Shirish S.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2021, 15 (04)
  • [42] The expression of methyl CpG binding factor MeCP2 correlates with cellular differentiation in the developing rat brain and in cultured cells
    Jung, BP
    Jugloff, DGM
    Zhang, GM
    Logan, R
    Brown, S
    Eubanks, JH
    JOURNAL OF NEUROBIOLOGY, 2003, 55 (01): : 86 - 96
  • [43] A WW domain binding region in methyl-CpG-binding protein MeCP2:: impact on Rett syndrome
    Buschdorf, JP
    Strätling, WH
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2004, 82 (02): : 135 - 143
  • [44] Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex
    Xinsheng Nan
    Huck-Hui Ng
    Colin A. Johnson
    Carol D. Laherty
    Bryan M. Turner
    Robert N. Eisenman
    Adrian Bird
    Nature, 1998, 393 : 386 - 389
  • [45] Lack of Methyl-CpG Binding Protein 2 (MeCP2) Affects Cell Fate Refinement During Embryonic Cortical Development
    Gigli, Clementina Cobolli
    Scaramuzza, Linda
    De Simone, Marco
    Rossi, Riccardo L.
    Pozzi, Davide
    Pagani, Massimiliano
    Landsberger, Nicoletta
    Bedogni, Francesco
    CEREBRAL CORTEX, 2018, 28 (05) : 1846 - 1856
  • [46] Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex
    Nan, XS
    Ng, HH
    Johnson, CA
    Laherty, CD
    Turner, BM
    Eisenman, RN
    Bird, A
    NATURE, 1998, 393 (6683) : 386 - 389
  • [47] The biological functions of the methyl-CpG-binding protein MeCP2 and its implication in Rett syndrome
    Nan, XH
    Bird, A
    BRAIN & DEVELOPMENT, 2001, 23 : S32 - S37
  • [48] Nuclear Calcium Signaling Controls Methyl-CpG-binding Protein 2 (MeCP2) Phosphorylation on Serine 421 following Synaptic Activity
    Buchthal, Bettina
    Lau, David
    Weiss, Ursula
    Weislogel, Jan-Marek
    Bading, Hilmar
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (37) : 30967 - 30974
  • [49] Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein
    Watson, P
    Black, G
    Ramsden, S
    Barrow, M
    Super, M
    Kerr, B
    Clayton-Smith, J
    JOURNAL OF MEDICAL GENETICS, 2001, 38 (04) : 224 - 228
  • [50] Early life stress exacerbates behavioural and neuronal alterations in adolescent male mice lacking methyl-CpG binding protein 2 (Mecp2)
    Torres-Perez, Jose Vicente
    Martinez-Rodriguez, Elena
    Forte, Anabel
    Blanco-Gomez, Carlos
    Stork, Oliver
    Lanuza, Enrique
    Santos, Monica
    Agustin-Pavon, Carmen
    FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 2022, 16